Skip to main content
logo
SELLAS Life Sciences Group, Inc. (SLS)
NASDAQ: SLS · Real-Time Price · USD
11.74
+0.41 (3.62%)
At close: Oct 2, 2026, 4:00 PM EDT
11.78
+0.04 (0.38%)
After-hours: Oct 2, 2026, 7:59 PM EDT

SLS Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
2,37153773344988
Market Cap Growth
1231.93%633.64%115.38%-30.05%-44.69%59.80%
Enterprise Value
2,23349353312862
Last Close Price
11.743.771.041.062.365.53

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
----48.5911.56
PB Ratio
17.227.587.73-4.2610.024.32
P/TBV Ratio
17.477.799.69-16.544.77

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
----28.288.21

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.010.010.11-0.110.200.04
Net Debt / Equity Ratio
-1.00-1.00-1.360.20-3.33-1.01
Net Debt / FCF Ratio
4.842.490.360.050.680.79
Asset Turnover
----0.040.21
Quick Ratio
18.2810.231.460.181.104.29
Current Ratio
18.8310.721.720.231.144.63
Return on Equity (ROE)
-39.63%-66.88%-4147.88%--327.81%-85.70%
Return on Assets (ROA)
-23.30%-34.74%-153.57%-174.27%-84.58%-33.87%
Return on Capital Employed (ROCE)
-24.00%-38.10%-317.60%503.80%-588.60%-92.00%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-1.37%-5.00%-42.19%-109.87%-85.00%-23.56%
FCF Yield
-1.20%-5.29%-48.37%-92.42%-49.00%-29.62%
Buyback Yield / Dilution
-86.04%-78.18%-120.33%-43.21%-25.29%-94.07%
SEC Filings: 10-K · 10-Q